greenTEG AG offers to sponsor Covid-19 research with its unique fever-monitor

Zurich, March 23rd, 2020


The current COVID-19 global pandemic raises many challenges for individuals, companies, and governments. As the disease has spread to well nearly 200 countries, the devastating health and socio-economic impact of the pandemic becomes evident. Consequently, these developments have sparked wide-scale initiatives by companies and individuals to develop new tools like vaccines, protective equipment, or monitoring solutions to assist in the battle of this unexpected crisis.

Fever is the most common initial symptom[1] of the virus and this is where greenTEG wants to help. Our non-invasive and continuous core body temperature monitoring patch enables early fever detection using only skin contact. The accuracy of the device has been verified in multiple clinical studies.

We believe that our solution can reduce the strain on the healthcare system by monitoring healthcare professionals exposed to the virus and by furthermore monitoring general ward patients, thus freeing up precious nursing resources. The device can further be effective for scientists researching the influence of the novel Coronavirus on the body temperature (e.g. temperature patterns).

greenTEG is offering its expertise and its technology as a contribution to overcome the current Corona crisis faster and with less sacrifice. greenTEG is willing to sponsor sensors for selected medical research on Covid-19 patients or health care workers. At the same time greenTEG is looking for partners capable of bringing its continuous and non-invasive core body temperature monitoring solution to the market as quickly as possible.  Interested researchers or clinicians as well as potential commercialization partners, please contact us at You can also download our one pager for more information. Please, don't forget to share it with anybody that could be interested.

You can dowload the press note in English clicking here.

For the French press note, please follow this link.

For the German version of the press release, click here.

[1] 98.6% of patients showed fever at onset of a diagnosed Covid-19 infection according to Wang D, 07.02.2020: Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia

More news

New research paper on Super-Planckian Radiative Heat Transfer published

Read more

Towards Online Personalized-Monitoring of Human Thermal Sensation Using Machine Learning Approach

Read more

CORE will officially supply Team BORA-hansgrohe in 2021

Read more

greenTEG’s gSKIN® BodyTEMP Patch used in membrane-assisted radiant cooling system study

Read more

greenTEG AG launches COREmedical in the U.S. as a clinical thermometer

Read more

greenTEG at the Tour de France

Read more

Thermal bridge effect of vertical diagonal tie connectors in precast concrete sandwich panels: an experimental and computational study

Read more

greenTEG flies to the International Space Station!

Read more
Read all